Registration Dossier

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

During the challenge phase,no dermal reactions were seen in any of the test or control animals.Based on these results,isodecyl benzoate did not produce evidence of skin sensitisation (delayed contact hypersensitivity) in any of the ten test animals and does not require labeling with the risk phrase R43 "May cause sensitization by skin contact” in accordance with Council Directive 79/831/EEC Annex VI, Part 11(D) as described in Commission Directive 93/21/EEC.

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)

Justification for classification or non-classification

Isodecyl benzoate does not require labeling with the risk phrase R43 "May cause sensitization by skin contact” in accordance with Council Directive 79/831/EEC Annex VI, Part 11(D) as described in Commission Directive 93/21/EEC.